Suit Says Cytodyne Omitted Side Effects From Ephedra-Free Supplement Label
This article was originally published in The Tan Sheet
Executive Summary
The New Jersey Attorney General's Office and the state's Division of Consumer Affairs are seeking to enjoin Cytodyne Technologies from making or disseminating further advertisements that contain unsubstantiated claims about its Xenadrine EFX ephedra-free dietary supplement